|
Market Closed -
NYSE
01:30:02 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 183.64 USD | -1.32% |
|
-1.96% | +61.64% |
| 21/10 | Dialysis Providers Under Pressure - U.S. Kidney Care Plan | DP |
| 15/10 | Davita Brings New Clinical Research to Asn Kidney Week, Advancing Evidence for the Next Era of Kidney Care | CI |
| Market Cap | 1.17TCr 1.05TCr 966.12Cr 875.52Cr 1.64TCr 1,11200Cr 1.67TCr 12TCr 4.6TCr 58TCr 4.4TCr 4.3TCr 1,83600Cr | P/E 2026 * |
12.6x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.25TCr 2.01TCr 1.86TCr 1.68TCr 3.15TCr 2,13900Cr 3.2TCr 22TCr 8.86TCr 1,12100Cr 8.46TCr 8.28TCr 3,53400Cr | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 1.54x |
| Free-Float |
49.06% | Yield 2026 * |
0.91% | Yield 2027 * | 0.91% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DVA | Delayed | |
CBOE
| DVA | Real-time | |
London S.E.
| 0I7E | Delayed | |
Tradegate
| TRL | Real-time | |
Mexican S.E.
| DVA * | End-of-day quote | |
Deutsche Boerse AG
| TRL | Delayed | |
Börse Stuttgart
| TRL | Delayed | |
Boerse Muenchen
| TRL | Real-time | |
Berne S.E.
| TRL | End-of-day quote | |
Borsa Italiana
| 1DVA | End-of-day quote | |
Xetra
| TRL | Delayed |
Last Transcript: DaVita Inc.
| 1 day | -1.32% | ||
| 1 week | -1.96% | ||
| Current month | +4.99% | ||
| 1 month | +0.27% | ||
| 3 months | -21.61% | ||
| 6 months | +18.45% | ||
| Current year | +61.64% |
| 1 week | 171.09 | 191.2 | |
| 1 month | 171.09 | 191.2 | |
| Current year | 101 | 247.49 | |
| 1 year | 101 | 247.49 | |
| 3 years | 75.47 | 247.49 | |
| 5 years | 65.28 | 247.49 | |
| 10 years | 43.4 | 247.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 65 | 01/06/2019 |
Joel Ackerman
DFI | Director of Finance/CFO | 61 | 27/02/2017 |
David Maughan
COO | Chief Operating Officer | 49 | 15/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 72 | 01/06/2020 |
Barbara Desoer
BRD | Director/Board Member | 73 | 08/10/2015 |
Javier Rodriguez
BRD | Director/Board Member | 65 | 01/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/09/26 | Tax | Chief Operating Officer | -7,501 | 0.0118% | ||
| 15/08/26 | Free | Director | 278 | 0.0004% | ||
| 15/08/26 | Free | Chairman | 278 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.32% | -1.96% | +43.45% | +132.84% | 1.17TCr | ||
| -1.07% | +1.20% | +15.30% | +35.48% | 12TCr | ||
| +0.37% | +2.22% | +6.56% | +94.67% | 10TCr | ||
| +0.64% | +2.67% | +107.15% | +907.86% | 5.82TCr | ||
| +1.75% | +2.27% | -5.86% | +82.21% | 2.91TCr | ||
| -0.57% | +2.93% | +32.01% | +99.17% | 2.67TCr | ||
| -0.30% | +3.46% | +15.83% | +66.20% | 2.67TCr | ||
| -0.81% | +0.45% | +29.74% | +391.13% | 2.16TCr | ||
| -2.46% | -5.71% | -23.17% | -7.12% | 1.96TCr | ||
| -0.68% | +2.72% | +4.02% | +82.89% | 1.89TCr | ||
| Average | -0.44% | +0.62% | +22.50% | +188.53% | 4.34TCr | |
| Weighted average by Cap. | -0.28% | +1.55% | +24.48% | +195.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.42TCr 1.26TCr 1.17TCr 1.06TCr 1.98TCr 1,34400Cr 2.01TCr 14TCr 5.56TCr 70TCr 5.31TCr 5.2TCr 2,22000Cr | 1.46TCr 1.31TCr 1.21TCr 1.09TCr 2.05TCr 1,39000Cr 2.08TCr 15TCr 5.75TCr 73TCr 5.49TCr 5.38TCr 2,29500Cr |
| Net income | 94Cr 84Cr 78Cr 70Cr 131.44Cr 8.92TCr 133.62Cr 932.95Cr 369.36Cr 4.67TCr 352.69Cr 345.19Cr 15TCr | 100.94Cr 90Cr 83Cr 75Cr 141.19Cr 9.58TCr 143.52Cr 1TCr 396.74Cr 5.02TCr 378.83Cr 370.78Cr 16TCr |
| Net Debt | 1.08TCr 966.56Cr 892.91Cr 809.18Cr 1.51TCr 1,02700Cr 1.54TCr 11TCr 4.25TCr 54TCr 4.06TCr 3.98TCr 1,69700Cr | 1.08TCr 964.56Cr 891.07Cr 807.51Cr 1.51TCr 1,02500Cr 1.54TCr 11TCr 4.25TCr 54TCr 4.05TCr 3.97TCr 1,69400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $183.64 | -1.32% | 6,18,098 |
| 22/26/22 | $186.10 | +5.25% | 9,31,346 |
| 21/26/21 | $176.81 | +0.83% | 11,40,395 |
| 20/26/20 | $175.35 | -6.23% | 20,71,606 |
| 19/26/19 | $187.00 | -0.17% | 3,25,523 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DVA Stock
Select your edition
All financial news and data tailored to specific country editions

















